Literature DB >> 2202694

Hyperthermia in cancer treatment.

K Hynynen1, B A Lulu.   

Abstract

Hyperthermia, used as an adjunct to radiation therapy, can increase tumor regression significantly. When used as a local (as opposed to regional or systemic) modality, proper treatment requires detailed knowledge of tumor and normal tissue geometry, and physiologic parameters such as perfusion and thermal conductivity. A brief review of local heating techniques and details of two techniques used to treat brain tumors are provided: Scan Focused Ultrasound and Interstitial Ferromagnetic Seed Implants. These techniques require the most sophisticated use of diagnostic radiology methods. Data from several modalities such as CT, MRI, angiography, and xenon CT perfusion studies must be merged into a consistent data set. This data set must be indexed precisely relative to the treatment apparatus. Real-time noninvasive temperature monitoring of the treatment field has not been achieved at this time, but is of interest to researchers in hyperthermia.

Entities:  

Mesh:

Year:  1990        PMID: 2202694     DOI: 10.1097/00004424-199007000-00014

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  11 in total

1.  Multiple-fraction-per-day external beam radiotherapy for adults with supratentorial malignant gliomas.

Authors:  E C Halperin
Journal:  J Neurooncol       Date:  1992-11       Impact factor: 4.130

2.  Safety trial of high-intensity focused ultrasound therapy for pancreatic cancer.

Authors:  Atsushi Sofuni; Fuminori Moriyasu; Takatomo Sano; Fumihide Itokawa; Takayoshi Tsuchiya; Toshio Kurihara; Kentaro Ishii; Syujiro Tsuji; Nobuhito Ikeuchi; Reina Tanaka; Junko Umeda; Ryosuke Tonozuka; Mitsuyoshi Honjo; Shuntaro Mukai; Mitsuru Fujita; Takao Itoi
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

Review 3.  Ultrasound-based triggered drug delivery to tumors.

Authors:  Ankit Jain; Ankita Tiwari; Amit Verma; Sanjay K Jain
Journal:  Drug Deliv Transl Res       Date:  2018-02       Impact factor: 4.617

4.  High intensity focused ultrasound in clinical tumor ablation.

Authors:  Yu-Feng Zhou
Journal:  World J Clin Oncol       Date:  2011-01-10

Review 5.  High-intensity focused ultrasound: advances in technology and experimental trials support enhanced utility of focused ultrasound surgery in oncology.

Authors:  G Malietzis; L Monzon; J Hand; H Wasan; E Leen; M Abel; A Muhammad; P Price; P Abel
Journal:  Br J Radiol       Date:  2013-02-12       Impact factor: 3.039

6.  High-intensity focused ultrasound (HIFU) for pancreatic carcinoma: evaluation of feasibility, reduction of tumour volume and pain intensity.

Authors:  Milka Marinova; Maximilian Rauch; Martin Mücke; Roman Rolke; Maria A Gonzalez-Carmona; Jana Henseler; Henning Cuhls; Lukas Radbruch; Christian P Strassburg; Lian Zhang; Hans H Schild; Holger M Strunk
Journal:  Eur Radiol       Date:  2016-02-17       Impact factor: 5.315

Review 7.  High-intensity focused ultrasound in the treatment of breast tumours.

Authors:  Mirjam C L Peek; Feng Wu
Journal:  Ecancermedicalscience       Date:  2018-01-10

Review 8.  Targeting the extracellular matrix for immunomodulation: applications in drug delivery and cell therapies.

Authors:  Samira Aghlara-Fotovat; Amanda Nash; Boram Kim; Robert Krencik; Omid Veiseh
Journal:  Drug Deliv Transl Res       Date:  2021-06-26       Impact factor: 4.617

9.  Ganoderma Lucidum Polysaccharides Enhance the Abscopal Effect of Photothermal Therapy in Hepatoma-Bearing Mice Through Immunomodulatory, Anti-Proliferative, Pro-Apoptotic and Anti-Angiogenic.

Authors:  Qing-Hai Xia; Cui-Tao Lu; Meng-Qi Tong; Meng Yue; Rui Chen; De-Li Zhuge; Qing Yao; He-Lin Xu; Ying-Zheng Zhao
Journal:  Front Pharmacol       Date:  2021-07-06       Impact factor: 5.810

Review 10.  High-Intensity Focused Ultrasound Circular Cyclocoagulation in Glaucoma: A Step Forward for Cyclodestruction?

Authors:  Rodolfo Mastropasqua; Vincenzo Fasanella; Alessandra Mastropasqua; Marco Ciancaglini; Luca Agnifili
Journal:  J Ophthalmol       Date:  2017-04-22       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.